These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1677 related items for PubMed ID: 12968110

  • 1. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S, Petrow-Sadowski C, Laughlin MJ, Ruscetti FW.
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [Abstract] [Full Text] [Related]

  • 2. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM, Fortuna A, Fogli M, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H, Little MT, Dragowska W, Thornbury G, Lansdorp PM.
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [Abstract] [Full Text] [Related]

  • 4. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.
    Cipolleschi MG, D'Ippolito G, Bernabei PA, Caporale R, Nannini R, Mariani M, Fabbiani M, Rossi-Ferrini P, Olivotto M, Dello Sbarba P.
    Exp Hematol; 1997 Oct; 25(11):1187-94. PubMed ID: 9328456
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells.
    Josefsen D, Myklebust JH, Lømo J, Sioud M, Blomhoff HK, Smeland EB.
    Stem Cells; 2000 Oct; 18(4):261-72. PubMed ID: 10924092
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S.
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [Abstract] [Full Text] [Related]

  • 7. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay.
    Fortunel N, Hatzfeld J, Kisselev S, Monier MN, Ducos K, Cardoso A, Batard P, Hatzfeld A.
    Stem Cells; 2000 Dec; 18(2):102-11. PubMed ID: 10742382
    [Abstract] [Full Text] [Related]

  • 8. Purification and release from quiescence of umbilical cord blood early progenitors reveal their potential to engraft adults.
    Hatzfeld J, Batard P, Cardoso AA, Li ML, Panterne B, Sansilvestri P, Ginsbourg M, Levesque JP, Hatzfeld A.
    Blood Cells; 1994 Dec; 20(2-3):430-4; discussion 434-5. PubMed ID: 7538349
    [Abstract] [Full Text] [Related]

  • 9. TGF-beta and MIP-1 alpha exert their main inhibitory activity on very primitive CD34+2CD38- cells but show opposite effects on more mature CD34+CD38+ human hematopoietic progenitors.
    Van Ranst PC, Snoeck HW, Lardon F, Lenjou M, Nijs G, Weekx SF, Rodrigus I, Berneman ZN, Van Bockstaele DR.
    Exp Hematol; 1996 Nov; 24(13):1509-15. PubMed ID: 8950234
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus.
    Lardon F, Snoeck HW, Nijs G, Lenjou M, Peetermans ME, Rodrigus I, Berneman ZN, Van Bockstaele DR.
    Exp Hematol; 1994 Aug; 22(9):903-9. PubMed ID: 7520393
    [Abstract] [Full Text] [Related]

  • 11. CD34+ cell expansion and expression of lineage markers during liquid culture of human progenitor cells.
    Warren MK, Rose WL, Beall LD, Cone J.
    Stem Cells; 1995 Mar; 13(2):167-74. PubMed ID: 7540470
    [Abstract] [Full Text] [Related]

  • 12. In vitro proliferation and differentiation of erythroid progenitors of cord blood.
    Sakatoku H, Inoue S.
    Stem Cells; 1997 Mar; 15(4):268-74. PubMed ID: 9253110
    [Abstract] [Full Text] [Related]

  • 13. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L, Zeng L, Hiti AL, Weinberg KI, Malik P.
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [Abstract] [Full Text] [Related]

  • 14. Synergy among erythropoietin, interleukin 3, stem cell factor (c-kit ligand) and interferon-gamma on early human hematopoiesis.
    Kawano Y, Takaue Y, Hirao A, Sato J, Abe T, Suzue T, Saito S, Okamoto Y, Kuroda Y.
    Stem Cells; 1994 Sep; 12(5):514-20. PubMed ID: 7528591
    [Abstract] [Full Text] [Related]

  • 15. Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line.
    Nishi N, Ishikawa R, Inoue H, Nishikawa M, Kakeda M, Yoneya T, Tsumura H, Ohashi H, Yamaguchi Y, Motoki K, Sudo T, Mori KJ.
    Exp Hematol; 1996 Sep; 24(11):1312-21. PubMed ID: 8862442
    [Abstract] [Full Text] [Related]

  • 16. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.
    Lu L, Leemhuis T, Srour EF, Yang YC.
    Exp Hematol; 1992 May; 20(4):418-24. PubMed ID: 1373687
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
    Traycoff CM, Abboud MR, Laver J, Brandt JE, Hoffman R, Law P, Ishizawa L, Srour EF.
    Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-11 (IL-11) and IL-9 counteract the inhibitory activity of transforming growth factor beta 3 (TGF-beta 3) on human primitive hematopoietic progenitor cells.
    Lemoli RM, Fogli M, Fortuna A, Tura S.
    Haematologica; 1995 Feb; 80(1):5-12. PubMed ID: 7758992
    [Abstract] [Full Text] [Related]

  • 19. Influence of retroviral-mediated gene transduction of both the recombinant human erythropoietin receptor and interleukin-9 receptor genes into single CD34++CD33-or low cord blood cells on cytokine-stimulated erythroid colony formation.
    Lu L, Ge Y, Li ZH, Xiao M, Broxmeyer HE.
    Exp Hematol; 1996 Feb; 24(2):347-51. PubMed ID: 8641364
    [Abstract] [Full Text] [Related]

  • 20. Special susceptibility to apoptosis of CD1a+ dendritic cell precursors differentiating from cord blood CD34+ progenitors.
    Canque B, Camus S, Yagello M, Gluckman JC.
    Stem Cells; 1998 Feb; 16(3):218-28. PubMed ID: 9617897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.